Addressing statin adverse effects in the clinic: the 5 Ms. (Q38207488)

31 August 2017

Addressing statin adverse effects in the clinic: the 5 Ms. (English)

1 reference

31 August 2017

Daniel H Katz

1

1 reference

ORCID Public Data File 2021

author name string

Sunny S Intwala

series ordinal

2

1 reference

PubMed ID

24770611

31 August 2017

Neil J Stone

series ordinal

3

1 reference

31 August 2017

25 April 2014

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

31 August 2017

1 reference

31 August 2017

19

1 reference

31 August 2017

6

1 reference

31 August 2017

533-542

1 reference

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.

31 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Being well-informed about statin is associated with continuous adherence and reaching targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Narrative review: statin-related myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

The role of coenzyme Q10 in statin-associated myopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Effect of statins on skeletal muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Emphasizing statin safety in the hospitalized patient: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Cognitive impairment associated with atorvastatin and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Simvastatin-associated memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Statin-associated adverse cognitive effects: survey results from 171 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

The controversies of statin therapy: weighing the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Statins and cognitive function in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Statins and cognitive function: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Statin safety: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Medication adherence: hope for improvement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414529622

21 January 2018

Identifiers

DOI

10.1177/1074248414529622

1 reference

31 August 2017

1 reference

PubMed ID

24770611